PRESS RELEASES

April 26, 2023
Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines
Learn More
September 27, 2022
Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines
Learn More

Awards and Recognition

BioSpace's NextGen Class of 2024
Learn More
2023 Endpoints 11
Learn More
BostInno’s 2023 Startups to Watch
BioTech Breakthrough Awards – 2023 BioTech Startup of the Year Medicines
© 2024 Orbital Therapeutics  •  Privacy Policy  •  Terms Of Use
 
 

This links to an external website.

Continue